Pharmaceutical R&D for Stroke

Ace Therapeutics is committed to the preclinical phase of stroke drug development, covering everything from model construction, target identification to preclinical candidates and beyond with the flexibility required. We offer a broad portfolio of services and a global network of partners that enable us to provide end-to-end services for small molecule and biomolecule drug discovery in stroke.

Pharmaceutical R&D for Stroke